Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02656641
Recruitment Status : Completed
First Posted : January 15, 2016
Last Update Posted : July 19, 2017
Sponsor:
Collaborator:
Immaculata University
Information provided by (Responsible Party):
Christiana Care Health Services

Brief Summary:
This study will assess the effects of client feedback, using the Patient Health Questionnaire - 9 and Generalized Anxiety Disorder 7-Item Scale, on depression and anxiety in individuals undergoing brief psychotherapy. Client feedback allows therapists to monitor treatment progress in real time. Identifying an easily accessible treatment intervention, which utilizes commonly used scales, that potentially enhances the effect of brief psychotherapy and improves treatment outcomes is a valuable endeavor with clear implications for therapy practices. It is hypothesized that clients who complete these scales each session will show greater symptom improvement than clients who do not complete the scales.

Condition or disease Intervention/treatment Phase
Depressive Symptoms Anxiety States, Neurotic Behavioral: Continuous Client Feedback Behavioral: Continuous Self Feedback Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 81 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item Scale (GAD-7) as Feedback Instruments in Brief Psychotherapy
Study Start Date : November 2015
Actual Primary Completion Date : August 31, 2016
Actual Study Completion Date : August 31, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
No Intervention: Control
Clients will complete symptom and quality of life scales before their first session and before their last or tenth session, whichever occurs first. Clients will not complete any scales during other sessions.
Experimental: Continuous Client Feedback
Clients will complete symptom and quality of life scales before their first session and before their last or tenth session, whichever occurs first. Clients will then complete symptoms scales, specifically the Patient Health Questionnaire-9 and Generalized Anxiety Disorder 7-Item Scale before each other session. The treating clinician will review and discuss their results and at the beginning of each session.
Behavioral: Continuous Client Feedback
Clients complete rating scales before each therapy session. The therapist then views these results and discusses treatment progress with the client during the session.

Experimental: Continuous Self Feedback
Clients will complete symptom and quality of life scales before their first session and before their last or tenth session, whichever occurs first. Clients will then complete symptoms scales, specifically the Patient Health Questionnaire-9 and Generalized Anxiety Disorder 7-Item Scale before each other session. The treating clinician will not have access to these results.
Behavioral: Continuous Self Feedback
Clients complete rating scales before each therapy session. Progress is not reviewed with the therapist.




Primary Outcome Measures :
  1. Change in depressive symptoms as assessed by Patient Health Questionnaire-9 [ Time Frame: Baseline and end of treatment up to 10 weeks ]
    Assesses depressive symptoms

  2. Change in anxiety symptoms as assessed by Generalized Anxiety Disorder 7-Item Scale [ Time Frame: Baseline and end of treatment up to 10 weeks ]
    Assesses anxiety symptoms


Secondary Outcome Measures :
  1. World Health Organization - Quality of Life BREF Scale [ Time Frame: Baseline and end of treatment up to 10 weeks ]
    Assesses domains of physical health, psychological health, social relationships, and environment

  2. Schwartz Outcome Scale [ Time Frame: Baseline and end of treatment up to 10 weeks ]
    Monitors treatment outcomes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of Major Depressive Disorder, Generalized Anxiety Disorder, or Adjustment Disorder

Exclusion Criteria:

  • Require a higher level of care than brief psychotherapy, or have been diagnosed with an intellectual disability, personality disorder, substance use disorder, or major medical illness

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02656641


Locations
Layout table for location information
United States, Delaware
Christiana Care Health System - Adult Bridge Program
Wilmington, Delaware, United States, 19801
Sponsors and Collaborators
Christiana Care Health Services
Immaculata University
Investigators
Layout table for investigator information
Principal Investigator: Krystal G Ludwig, MA Christiana Care Health Services